Growth Metrics

Haemonetics (HAE) Cash from Operations (2016 - 2025)

Haemonetics has reported Cash from Operations over the past 17 years, most recently at 93564000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations rose 113.78% year-over-year to 93564000.0; the TTM value through Dec 2025 reached 338837000.0, up 162.16%, while the annual FY2025 figure was 181725000.0, 0.01% changed from the prior year.
  • Cash from Operations for Q4 2025 was 93564000.0 at Haemonetics, down from 111321000.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 116557000.0 in Q1 2025 and troughed at 27421000.0 in Q2 2024.
  • A 5-year average of 51631200.0 and a median of 55628000.0 in 2022 define the central range for Cash from Operations.
  • On a YoY basis, Cash from Operations climbed as much as 8204.81% in 2024 and fell as far as 243.67% in 2024.
  • Year by year, Cash from Operations stood at 43460000.0 in 2021, then soared by 48.22% to 64415000.0 in 2022, then tumbled by 100.84% to 540000.0 in 2023, then surged by 8204.81% to 43766000.0 in 2024, then surged by 113.78% to 93564000.0 in 2025.
  • Business Quant data shows Cash from Operations for HAE at 93564000.0 in Q4 2025, 111321000.0 in Q3 2025, and 17395000.0 in Q2 2025.